A research team, with participation from the DZL, has developed an innovative human “lung-on-a-chip” model that realistically replicates key mechanisms of ventilator-associated pneumonia (VAP).
A recent scientific statement from the American Heart Association, published in the journal Circulation, places greater emphasis on right ventricular function in both research and clinical care for pulmonary hypertension (PH).
A newly developed nanobody could significantly expand treatment options for cystic fibrosis. For the first time, researchers have succeeded in engineering a cell-permeable antibody fragment that acts directly inside cells and stabilises the CFTR channel,...
A recent study published in the Journal of Controlled Release explores innovative strategies to deliver RNA-based therapies directly to the lungs. The findings provide important impulses for the development of new treatment approaches for inflammatory...
A recent study involving researchers from the DZL shows that increased airway resistance may serve as an early indicator of future lung damage, even in seemingly healthy smokers. The findings were published in the American...
Despite major advances in research, many cases of bronchiectasis remain idiopathic. DZL researchers are now investigating whether subtle CFTR dysfunction may play an underappreciated role.
A recent study published in the European Respiratory Journal provides important new insights into the early identification and monitoring of chronic obstructive pulmonary disease (COPD). The focus is on airway wall thickness as an imaging...
At the launch of the nationwide lung cancer screening program, DZL board member Hans-Ulrich Kauczor explains the opportunities, risks, and challenges of early detection in an interview with the Frankfurter Allgemeine Zeitung.
DZL Academy member Claudia V. Benke has been selected as a Scientific Ambassador of Euro-BioImaging for 2026. She is one of eleven researchers across Europe to receive this recognition.
DZL congratulates Werner Seeger and Claus Vogelmeier on being named honorary members of the DGP, recognizing their outstanding contributions to pneumology and lung research in Germany.
Many people continue to experience breathing difficulties, fatigue, or coughing months after a SARS-CoV-2 infection—a condition known as Long COVID. But what changes in the immune system lead to lasting lung impairment?
Two scientists from the German Center for Lung Research (DZL) have been awarded the prestigious René Baumgart Foundation Research Prize. The award ceremony took place during the 66th Congress of the German Respiratory Society in...
